Document 0698 DOCN M9590698 TI Real time assay for the hiv-1 integrase 3'-processing reaction using a novel fluorescent guanosine analog. DT 9509 AU Hawkins ME; Pfleiderer W; Balis FM; Pediatric Branch, National Cancer Institute, Bethesda, MD SO NIH Conf Retroviral Integrase. 1995 Jan 19-20;:(Participants' abstracts and posters, abstract no. 2). Unique Identifier : AIDSLINE AIDS/95920021 AB Fluorescence is an important tool for studying protein/DNA interactions because fluorophores are sensitive to changes in their molecular environment and reflect those changes through measurable differences in fluorescence. Unfortunately, most fluorophores are large molecules and, when linked to DNA, their presence can change the tertiary structure of DNA or interfere with binding and mobility. We have developed a highly fluorescent pteridine, 3-methyl-8- (2-deoxy beta-D-ribofuranosyl) isoxanthopterin (3-MI), which is a structural analog of guanosine. In its phosphoramidite form, 3-MI can be site-specifically inserted into an oligonucleotide using an automated DNA synthesizer. Because 3-MI is inserted into the DNA through a 3',5'-phosphodiester linkage identical to that of naturally occurring nucleotides, it is less likely to alter the conformation of DNA or interfere with protein/DNA interactions than fluorophores which are linked externally to DNA. Insertion of 3-MI into an oligonucleotide partially quenches its fluorescence intensity. This new fluorophore was used to develop a real time assay for monitoring the HIV-1 integrase 3'processing reaction. Purified recombinant enzyme is incumbated with a short oligonucleotide (21-mer) with a sequence identical to the U5 terminus of HIV-1 DNA with 3-MI substituted for guanosine at the cleavage site. When the 3'-terminal dinucleotide containing 3-MI is cleaved by integrase, fluorescence intensity increases at a rate proportional to the rate of the reaction. The change in fluorescence can be monitored in real time by performing the reaction in a spectrofluorometer. Because the change in fluorescence intensity is dependent on release of the 3-MI- containing dinucleotide, this assay is specific for the 3'- processing reaction. Using this assay, we studied the role of cofactor and substrate concentration on the rate of the 3'-processing reaction, as well as the effect of the chelating agent, EDTA, which binds the required divalent cation, Mn2+. In the absence of M2+ there is no change in fluorescence intensity confirming that it is a required cofactor. The reaction did not proceed unless the Mn2+ was added to the reaction mixture (containing the oligonucleotide substrate) before integrase, suggesting that integrase must interact with Mn2+ before binding to the DNA substrate. The optimal Mn2+ concentration in our assay system was 7.5-15 nM. Pre-incubation of the enzyme with EDTA prior to the addition of enzyme to the reaction mixture completely inhibits the reaction, but pre-incubation of the reactants with EDTA prior to the addition of enzyme did not immediately inhibit the reaction, presumably because of Mn2+ bound to integrase in the enzyme preparation. The minimum EDTA concentration necessary to stop a reaction which is in progress is 8.0 nM in the presence of 7.5 mM Mn2+. However, EDTA added to a reaction in progress does not stop the reaction immediately. With increasing substrate concentration, there was evidence of substrate inhibition at concentrations exceeding 164 nM. This novel real time assay for integrase should prove useful for further mechanistic studies of the enzyme and may provide a rapid means of screening for inhibitors, which could have therapeutic applications. DE Cations, Divalent DNA Nucleotidyltransferases/*METABOLISM DNA, Viral/GENETICS Edetic Acid/CHEMISTRY Fluorescent Dyes/*CHEMISTRY Guanosine/*CHEMISTRY HIV-1/*ENZYMOLOGY/GENETICS Manganese/CHEMISTRY Protein Processing, Post-Translational Spectrometry, Fluorescence Time Factors MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).